Teladoc Health Inc (NYSE:TDOC) SVP Andrew Turitz sold 8,202 shares of the stock in a transaction that occurred on Monday, December 3rd. The shares were sold at an average price of $64.14, for a total value of $526,076.28. Following the sale, the senior vice president now directly owns 9,378 shares of the company’s stock, valued at approximately $601,504.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
TDOC opened at $53.41 on Friday. The company has a quick ratio of 8.99, a current ratio of 8.99 and a debt-to-equity ratio of 0.40. The firm has a market capitalization of $4.19 billion, a price-to-earnings ratio of -32.37 and a beta of 0.92. Teladoc Health Inc has a 12-month low of $30.88 and a 12-month high of $89.05.
Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Thursday, November 1st. The health services provider reported ($0.34) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.36) by $0.02. The business had revenue of $111.00 million during the quarter, compared to the consensus estimate of $109.94 million. Teladoc Health had a negative return on equity of 14.05% and a negative net margin of 31.32%. The firm’s quarterly revenue was up 61.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($0.55) earnings per share. On average, equities analysts predict that Teladoc Health Inc will post -1.47 earnings per share for the current year.
A number of analysts recently commented on the company. Canaccord Genuity raised their price target on Teladoc Health from $86.00 to $94.00 and gave the stock a “buy” rating in a research note on Friday, September 28th. TheStreet raised Teladoc Health from a “d+” rating to a “c” rating in a research note on Wednesday, August 22nd. Leerink Swann assumed coverage on Teladoc Health in a research note on Thursday, August 16th. They issued an “outperform” rating and a $90.00 price target for the company. Robert W. Baird raised their price target on Teladoc Health from $65.00 to $80.00 and gave the stock a “neutral” rating in a research note on Friday, September 28th. Finally, Craig Hallum raised their price target on Teladoc Health from $70.00 to $80.00 and gave the stock a “buy” rating in a research note on Monday, October 15th. Four research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $85.06.
Institutional investors and hedge funds have recently bought and sold shares of the business. Harvest Fund Management Co. Ltd bought a new position in Teladoc Health in the third quarter worth $165,000. Signaturefd LLC bought a new position in Teladoc Health in the third quarter worth $173,000. D.A. Davidson & CO. bought a new position in Teladoc Health in the third quarter worth $210,000. National Asset Management Inc. bought a new position in Teladoc Health in the third quarter worth $224,000. Finally, Ibex Investors LLC bought a new position in Teladoc Health in the third quarter worth $224,000.
ILLEGAL ACTIVITY WARNING: This piece was posted by The Lincolnian Online and is owned by of The Lincolnian Online. If you are reading this piece on another website, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The original version of this piece can be read at https://www.thelincolnianonline.com/2018/12/08/andrew-turitz-sells-8202-shares-of-teladoc-health-inc-tdoc-stock.html.
Teladoc Health Company Profile
Teladoc Health, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.
Read More: Diversification
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.